Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RATHL: PET-Adapted Therapy in Advanced Hodgkin Lymphoma
NCT00678327Phase 3Completed
- Sponsor
- University College London
- Start
- Aug 2008
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bleomycin in Hodgkin lymphoma (HL), sponsored by University College London. Started Aug 2008; status: completed.
02
Drugs
bleomycin
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00678327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678327.